about
Role of Acetylsalicylic Acid in Cytokine Stimulation of Macrophages in Antibody-Dependent Cellular Cytotoxicity (ADCC)Nutrition and Gastrointestinal DiseaseAspirin in the Chemoprevention of Colorectal Neoplasia: An OverviewCollaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsGrowth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signalingMolecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary fieldSperm and oocyte communication mechanisms controlling C. elegans fertilityRole of bacteria in oncogenesisChronic immune activation and inflammation as the cause of malignancyEffects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysisJTE-522, a selective COX-2 inhibitor, inhibits growth of pulmonary metastases of colorectal cancer in ratsSuppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligandsAuthors' ReplyThe cancer stem cell: evidence for its origin as an injured autoreactive T cellInflammation in gastric cancer: Interplay of the COX-2/prostaglandin E2 and Toll-like receptor/MyD88 pathwaysThe Hen or the Egg: Inflammatory Aspects of Murine MPN ModelsEmerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancerAdipocytes: impact on tumor growth and potential sites for therapeutic interventionPotential role of aspirin in the prevention of aneurysmal subarachnoid hemorrhage.Microbiome, inflammation, and cancerUse of NSAIDs for the chemoprevention of colorectal cancerAspirin use and pancreatic cancer mortality in a large United States cohortRisk of breast cancer among users of aspirin and other anti-inflammatory drugsIncreased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitorsSelective suppression of CCAAT/enhancer-binding protein beta binding and cyclooxygenase-2 promoter activity by sodium salicylate in quiescent human fibroblastsFamiliar drugs may prevent cancerLong-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancerCelecoxib as adjunctive therapy for treatment of colorectal cancerAbsence of nuclear factor kappaB inhibition by NSAIDs in hepatocytesThe American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristicsInduction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cellsAspirin and sodium salicylate inhibit proliferation and induce apoptosis in rheumatoid synovial cellsNo excess risk of colorectal cancer among alcoholics followed for up to 25 yearsDo altering in ornithine decarboxylase activity and gene expression contribute to antiproliferative properties of COX inhibitors?Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based studyProstaglandin-independent effects of aspirin on cell cycle and putrescine synthesis in human colon carcinoma cellsCase-control study on the association of upper gastrointestinal bleeding and nonsteroidal anti-inflammatory drugs in JapanEffect of aspirin on the Wnt/beta-catenin pathway is mediated via protein phosphatase 2AEffect of cotreatment of aspirin metabolites on mitomycin C-induced genotoxicity using the somatic mutation and recombination test in Drosophila melanogasterTristetraprolin binds to the 3'-untranslated region of cyclooxygenase-2 mRNA. A polyadenylation variant in a cancer cell line lacks the binding site
P2860
Q21147009-B7F10D87-E966-4D07-9670-52F8CC139902Q22241264-21401DEF-2F6D-40BB-AE18-3752CD8E253FQ22306433-0084D676-0243-479B-B35A-3FB72EF9E4A6Q24555072-0F60F008-3E1B-451D-9EF0-BFB279AE6136Q24562718-00C32636-C0D7-4488-AE11-60E97BD1B485Q24620628-EB40B33F-C440-4583-861C-48D8F6EE17AAQ24626882-0B41CE00-CFB1-4CB6-996A-E7AEA0A1D86BQ24633180-F90CDEE7-B625-4AE0-8E08-2B27B63DDC2DQ24648532-298185B8-0970-470E-A2A8-A59C4BDAA8C4Q24796323-6146A3CF-CECD-4A1D-9188-33A0B6C8FE45Q24803701-2D73E05F-A498-4CD1-A0EC-57F395D1461DQ24810709-89AAD100-4FA3-4CB4-B2D8-59CC2EB98C55Q24813931-61224860-BDE5-4D2A-89DF-7D9CC9DF4CC2Q25256839-EA25044A-C202-40DD-8D1A-A9D4EC845A40Q26748123-1AED9C74-038F-42D0-8C49-F8F618DF01AAQ26778931-28298E1D-2690-45C0-9A38-98DC18F9044FQ26829126-DD091857-073B-4C1D-8AAE-ABB54E116FACQ26830077-58E23430-8532-47B7-9430-CDCA7EED3F92Q26998381-5E23C318-55E3-4A74-924E-974E74AF1C8CQ27027582-E2B32CBD-4A2E-4952-BE45-3AA7D91656D6Q28165741-E176A8CD-DCDB-4137-809A-B01EA1B69A60Q28168130-5F0B1BF5-C5B6-4E84-AB12-BB4B44E6A11CQ28169157-7659C8BE-FC4A-4D51-B2C0-EB112AE3CFCEQ28175922-C7E15DFD-3081-43F7-B09C-03B371089F81Q28181159-E685263E-EECF-427C-BF44-23DC342BF3DFQ28186835-4899B3CB-153A-43A2-8AF8-F35177B12DC1Q28188848-0EC2B8E5-382A-42F6-845F-DB1E7BD74FA4Q28192119-F9B32062-35DC-48D6-9D7C-1DEA53C52E0FQ28192297-3068772B-4855-452D-B687-684FA8AD4957Q28192567-93078BC4-E574-478A-AE2A-388035F6239BQ28193048-85ECF485-38F5-4309-8DB6-CB00689C4C10Q28194712-05C15C20-E579-4B6D-87BF-025675583C95Q28195581-A6B7DDA9-3A0F-4F2D-89CE-367E311D5EB1Q28195582-3E236E2D-7B12-437B-A532-4B4F76E23FBEQ28196301-75CC2E72-852C-4D48-918E-4C464292EE8CQ28196322-5A901F83-AEA2-4F24-BD3E-F1F7D34794CCQ28199071-63C5E614-3447-4BC5-9D1F-4A633A43AC2FQ28199885-A870395A-A4C4-4E94-86BE-CF46165D9DD1Q28200277-D3A1482F-08F1-4833-BACD-AC3D9D875746Q28208459-6FAA4512-EE7C-41CB-B14A-527382561EA9
P2860
description
1991 nî lūn-bûn
@nan
1991 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Aspirin use and reduced risk of fatal colon cancer.
@ast
Aspirin use and reduced risk of fatal colon cancer.
@en
Aspirin use and reduced risk of fatal colon cancer.
@nl
type
label
Aspirin use and reduced risk of fatal colon cancer.
@ast
Aspirin use and reduced risk of fatal colon cancer.
@en
Aspirin use and reduced risk of fatal colon cancer.
@nl
prefLabel
Aspirin use and reduced risk of fatal colon cancer.
@ast
Aspirin use and reduced risk of fatal colon cancer.
@en
Aspirin use and reduced risk of fatal colon cancer.
@nl
P2093
P1476
Aspirin use and reduced risk of fatal colon cancer.
@en
P2093
Heath CW Jr
Namboodiri MM
P304
P356
10.1056/NEJM199112053252301
P407
P577
1991-12-01T00:00:00Z